Cancer Research - 98Alive
Cancer is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumours, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukaemia, do not.
Cancer is a leading cause of death worldwide and affects people at all ages with the risk for most types increasing with age. Lung, stomach, liver, colon and breast cancer cause the most cancer deaths each year, with tobacco use the single most important risk factor for cancer. Cancer caused about 13% of all human deaths in 2007 (7.6 million) and more than 30% of cancer deaths can be prevented.
Currently there is no cure for cancer and the unfortunate exposure to cancer activating materials can be impossible to avoid. Whether our bodies will or will not form cancer is subject to numerous factors and are quite often beyond our control.
Cancer is thus a progressive disease, and these progressive errors slowly accumulate until a cell begins to act contrary to its function in the organism.
The testing in cell liner work and mice models shows that MAC/98alive™ kills these types of cancer and the main aims are in the application of MAC/98alive™ to these cancer areas.
Test 1: Cancer study by Griffith University, February 2008 (Australia)
Cervical, lung, and colon human cancers were grown in cell lines and exposed to MAC/98alive™. The study showed that all cancer cells were killed.
Test 2: Lung cancer research by Griffith University, 2008 (Australia)
A group of mice were fed MAC/98alive and then had lung cancer cells introduced into their bodies.
Another group of mice had lung cancer cells introduced first and were then fed MAC/98alive™.
A third group was used as the control group.
In the first group, the cancer cells would not grow and died.
The work that has been conducted to date has illustrated that all cancer cells that have been challenged by MAC/98alive™ have been terminated.
The latest murine studies (live mouse studies) which have focused on breast cancer conclusively show the eradication of the cancerous cells and complete deterioration of the tumor in four to eight days from a single injection.
Professor Reynolds believes that many types of cancer can be defeated with this simple but effective procedure with no side effects for the patient and minimal discomfort and in respect of breast cancer the avoidance of a mastectomy.
MAC/98alive™ offers a new way of low cost, effective and safe treatment option, with little to no side effects and will become the method of choice for the global treatment of cancer.